About the Reproductive Research Laboratory
World-Class Technology and Team: Establishing the Golden Standard for Embryology Laboratories
Lee Women’s Hospital has invested hundreds of millions of dollars to establish a professional Reproductive Research Laboratory that meets international standards. The laboratory integrates cutting-edge technologies, including AI-assisted in vitro fertilization, intracytoplasmic sperm injection (ICSI), and cryopreservation. All procedures are meticulously supervised by a PhD-level professional team together with senior embryologists, ensuring that every stage adheres to the strictest standards of quality and safety.

Expertise and Clinical Excellence: Led by Dr. Chun-Chia Huang, with Over 40 Years of Dedication
Pioneer of Taiwan’s Embryo Culturing | Dr. Chun-Chia Huang, Director of the Reproductive Research Laboratory Team, played a leading role in 1990 during the founding period of the Taiwan Society for Reproductive Medicine. He established standardized protocols for embryo culture and actively promoted the professional development of embryologists, earning the title of “ Godfather of Embryologist" in Taiwan. |
Highly Skilled and Experienced Research Team | The laboratory consists of 3 PhD-level embryologists, 14 master’s-level embryologists, and 5 bachelor’s-level embryologists. Among them, 4 are senior embryologists with over 30 years of experience. All members have been professionally trained under the direct mentorship of Dr. Chun-Chia Huang, ensuring that every detail can withstand the highest level of scrutiny. |
Active Participation in International Academic Conferences | Each year, the team is invited to attend leading global conferences such as the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). On average, they publish approximately 20 research papers annually in internationally renowned journals in reproductive medicine, making them one of the few teams in Taiwan distinguished by both strong clinical practice and robust research achievements. |
Adoption of the Latest Global Technologies and Equipment | Pioneered the adoption of Computer-Assisted Sperm Analysis (CASA) in Taiwan and promoted the use of individualized embryo incubators. 1993: Adopted Intracytoplasmic Sperm Injection (ICSI) from the United States, the United Kingdom, and Belgium. 2000s: Adopted vitrification cryopreservation technology from Japan. 2006: First adopted the spindle view technology for precise chromosome positioning in Taiwan. 2017: Adopted the time-lapse embryo imaging monitoring system and AI-based embryo selection algorithms. |


CAP International Accreditation in 2025: A Dual Guarantee of Quality and
The Reproductive Research Laboratory of Lee Women’s Hospital was awarded international accreditation by the College of American Pathologists (CAP), one of the world’s most authoritative accreditation organizations. CAP accreditation is renowned for its stringent review standards, covering laboratory operations, quality management, testing methodologies, and equipment control. Only a very limited number of reproductive medical institutions worldwide have achieved this international benchmark.
Professional reproductive medicine not only relies on the clinical expertise of doctors but also requires the laboratory to provide rigorous techniques and precise data as a solid foundation. This is the embodiment of Lee Women’s Hospital’s unwavering commitment to quality and its ability to align with international standards. This honor is not only a recognition of the team’s excellence but also a testament to our relentless pursuit of perfection and our dedication to safeguarding the hope of life.
Core Technologies Of Our Laboratory– Precision, Safety, and Personalization
Medical Systems and Quality Management – Data-Oriented and Clinically Validated

For more than 40 years, Lee Women’s Hospital has maintained a rigorous and continuous management system. The hospital places strong emphasis on clinical case follow-up and treatment outcome optimization. Three regular meetings are held every week—research conferences, journal club discussions, and clinical case review meetings—covering all aspects from research project planning to the analysis of patients who have not yet conceived. These comprehensive discussions and ongoing adjustments are designed to improve both pregnancy and live birth rates. Such a strict and sustained framework has been consistently implemented for over 4 decades, solely to fulfill the hopes of more families seeking to have children.
For every woman who comes to Lee Women’s Hospital, we provide the highest level of professionalism and compassionate care, walking alongside her on the journey toward the hope of building a complete family.








